On the other hand, there is strong evidence that TNF-α inhibitor therapy reduces the incidence of cardiovascular events in patients with inflammatory diseases such as rheumatoid arthritis (Jacobsson et al. 2007). Here, TNF is linked to rheumatoid arthritis.